Position in BIOA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$58,593,728
+$8,037,047 QoQ
Shares Held
2,390,605
-17.3% QoQ
Ownership
5.21%
of shares outstanding
% of Portfolio
2.98%
of 13F equity value
Holder Rank
#3
of 151 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cormorant Asset Management, LP holds $62,185,728 across 2 Drug Manufacturers - Specialty & Generic names. BIOA ranks #1 (94.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BIOA |
BioAge Labs, Inc.
This page
|
2,390,605 | $58,593,728 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
200,000 | $3,592,000 |
All Filings in BIOA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $58,593,728 | 2,390,605 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $58,593,728 | 2,390,605 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $50,556,681 | 2,890,605 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $26,997,204 | 2,040,605 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $12,586,757 | 2,140,605 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8,840,698 | 2,140,605 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,887,029 | 2,629,529 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $15,224,972 | 2,629,529 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $33,894,203 | 1,629,529 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||